标题/作者	年份
A framework for advancing our understanding of cancer-associated fibroblasts E Sahai, I Astsaturov, E Cukierman, DG DeNardo, M Egeblad, RM Evans, ... Nature Reviews Cancer 20 (3), 174-186	2020
Macrophages as regulators of tumour immunity and immunotherapy DG DeNardo, B Ruffell Nature Reviews Immunology 19 (6), 369-382	2019
Cancer immunoediting and resistance to T cell-based immunotherapy JS O’Donnell, MWL Teng, MJ Smyth Nature reviews Clinical oncology 16 (3), 151-167	2019
Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts E Elyada, M Bolisetty, P Laise, WF Flynn, ET Courtois, RA Burkhart, ... Cancer discovery 9 (8), 1102-1123	2019
Concepts of extracellular matrix remodelling in tumour progression and metastasis J Winkler, A Abisoye-Ogunniyan, KJ Metcalf, Z Werb Nature communications 11 (1), 5120	2020
A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia N Baryawno, D Przybylski, MS Kowalczyk, Y Kfoury, N Severe, ... Cell 177 (7), 1915-1932. e16	2019
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy T Liu, C Han, S Wang, P Fang, Z Ma, L Xu, R Yin Journal of hematology & oncology 12 (1), 1-15	2019
A single-cell atlas of the tumor and immune ecosystem of human breast cancer J Wagner, MA Rapsomaniki, S Chevrier, T Anzeneder, C Langwieder, ... Cell 177 (5), 1330-1345. e18	2019
Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing M Bartoschek, N Oskolkov, M Bocci, J Lövrot, C Larsson, M Sommarin, ... Nature communications 9 (1), 5150	2018
The dark side of fibroblasts: cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment L Monteran, N Erez Frontiers in immunology, 1835	2019
Therapeutic targeting of the tumor microenvironment L Bejarano, MJC Jordāo, JA Joyce Cancer discovery 11 (4), 933-959	2021
Multimodal analysis of composition and spatial architecture in human squamous cell carcinoma AL Ji, AJ Rubin, K Thrane, S Jiang, DL Reynolds, RM Meyers, MG Guo, ... Cell 182 (2), 497-514. e22	2020
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives X Mao, J Xu, W Wang, C Liang, J Hua, J Liu, B Zhang, Q Meng, X Yu, ... Molecular cancer 20 (1), 1-30	2021
Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy CX Dominguez, S Müller, S Keerthivasan, H Koeppen, J Hung, S Gierke, ... Cancer discovery 10 (2), 232-253	2020
Diversity and biology of cancer-associated fibroblasts G Biffi, DA Tuveson Physiological reviews	2020
The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses A Labani-Motlagh, M Ashja-Mahdavi, A Loskog Frontiers in immunology 11, 940	2020
Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance ME Fiori, S Di Franco, L Villanova, P Bianca, G Stassi, R De Maria Molecular cancer 18 (1), 1-16	2019
Cancer-associated fibroblasts build and secure the tumor microenvironment T Liu, L Zhou, D Li, T Andl, Y Zhang Frontiers in cell and developmental biology 7, 60	2019
In search of definitions: Cancer‐associated fibroblasts and their markers M Nurmik, P Ullmann, F Rodriguez, S Haan, E Letellier International journal of cancer 146 (4), 895-905	2020
TGFβ biology in cancer progression and immunotherapy R Derynck, SJ Turley, RJ Akhurst Nature Reviews Clinical Oncology 18 (1), 9-34	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。